Am I wrong to read this as a reference to Fusion (a recent US$1.4billion buyout by Astra Zeneca)!"... Alpha-emitter therapies, such as those involving actinium-225 (Ac-225or 225Ac) and lead-212 (Pb-212 or 212Pb), are generatinginterest,BUT;
a) Their commercialsupply chains are still in the early development phase, and they arecurrently very difficult to source.
b) They are YET TOSHOWsafety and efficacy in late-stage trials, as opposed to betaemitters, like Cu-67, that have a long history of effectiveness in treatingsolid tumors...."
If so (and I think it is) - GREAT!![]()
- Forums
- ASX - By Stock
- CU6
- Ann: Clarity enters into Clinical Supply Agreement
Ann: Clarity enters into Clinical Supply Agreement, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.13 |
Change
-0.170(2.70%) |
Mkt cap ! $1.910B |
Open | High | Low | Value | Volume |
$6.32 | $6.48 | $6.11 | $5.556M | 885.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.20 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 6.120 |
3 | 6551 | 6.110 |
7 | 4338 | 6.100 |
1 | 4000 | 6.090 |
1 | 5000 | 6.040 |
Price($) | Vol. | No. |
---|---|---|
6.200 | 5000 | 1 |
6.280 | 625 | 1 |
6.300 | 20400 | 1 |
6.320 | 220 | 1 |
6.350 | 27007 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |